The safety and tolerability of donepezil in patients with Alzheimer's disease.
about
Benefits of statistical molecular design, covariance analysis, and reference models in QSAR: a case study on acetylcholinesterase.Drugs for Alzheimer's disease: are they effective?Sundown syndrome in persons with dementia: an update.Donepezil in Alzheimer's disease: From conventional trials to pharmacogeneticsDonepezil in Alzheimer's disease: an evidence-based review of its impact on clinical and economic outcomes.Acetylcholinesterase inhibitors for the treatment of dementia in Alzheimer's disease: do we need new inhibitors?Targeting acetylcholinesterase to treat neurodegeneration.Donepezil: an update.Discrimination performance in aging is vulnerable to interference and dissociable from spatial memoryA Randomized, Crossover, Single-Dose Bioequivalence Study of Two Extended-Release Tablets of Donepezil 23 mg in Healthy Human Volunteers under Fasting and Fed States.Sleep in dementia and caregiving--assessment and treatment implications: a review.Donepezil provides positive effects to patients treated with gabapentin for neuropathic pain: an exploratory study.Bioequivalence study of donepezil hydrochloride tablets in healthy male volunteersIntra-operative bradycardia in a patient with Alzheimer's disease treated with two cholinesterase inhibitors.Donepezil-induced hepatotoxicity in an elderly adult taking fluoxetine.
P2860
Q30620538-A5FBEF52-F0B2-44DA-B6B0-06DF663E4266Q33865325-5C5636A7-07B9-4D96-B154-058F291D876FQ34244388-2C4DAA65-C418-43B1-9E72-7C534793A6FCQ34965949-0339ABAE-8AFB-4605-9001-D96BC623547BQ35876403-EE8D499E-3CFC-4A76-AAC6-C1E1AC4BBE4BQ36302845-D7F60A18-00EC-4F6D-AFF2-52932218A3CEQ36709537-72950243-970C-4CE0-A2DF-84BD328893EDQ36808057-BEAB307F-7FC9-4D78-83C7-759A936D99F4Q37032919-5DA34835-2A78-423F-B21D-CA225EB4CD49Q37218956-08AA354A-BF7B-4AB8-A30D-4539918CA432Q37800192-204BBACA-ADDF-4B8D-B2FA-4BB78C9F62BDQ39216950-1B329806-9958-4907-97C6-F7170F43AE9DQ41662439-D14102F8-226A-4781-B3D1-C19C866F5999Q48629686-D7B1929A-4AB5-4A7F-845E-85ABE52F06BCQ53357980-DE7D8336-5B39-49FE-95B1-CD5B468C307B
P2860
The safety and tolerability of donepezil in patients with Alzheimer's disease.
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The safety and tolerability of donepezil in patients with Alzheimer's disease.
@ast
The safety and tolerability of donepezil in patients with Alzheimer's disease.
@en
The safety and tolerability of donepezil in patients with Alzheimer's disease.
@nl
type
label
The safety and tolerability of donepezil in patients with Alzheimer's disease.
@ast
The safety and tolerability of donepezil in patients with Alzheimer's disease.
@en
The safety and tolerability of donepezil in patients with Alzheimer's disease.
@nl
prefLabel
The safety and tolerability of donepezil in patients with Alzheimer's disease.
@ast
The safety and tolerability of donepezil in patients with Alzheimer's disease.
@en
The safety and tolerability of donepezil in patients with Alzheimer's disease.
@nl
P2093
P2860
P1476
The safety and tolerability of donepezil in patients with Alzheimer's disease.
@en
P2093
David Wilkinson
Richard J Ham
Stephen Jackson
P2860
P356
10.1111/J.1365-2125.2004.01848.X
P407
P478
58 Suppl 1
P577
2004-11-01T00:00:00Z